Unichem Laboratories has received approval from the US health regulator for losartan potassium and hydrochlorothiazide tablets, used in the treatment of hypertension and reduction in risk of strokes in patients with hypertension.
The company “has received abbreviated new drug application (ANDA) approval from the United States Food and Drug Administration (USFDA) for losartan potassium and hydrochlorothiazide tablets USP, 50mg/12.5mg, 100mg/12.5 mg and 100mg/25mg,” Unichem Laboratories said in a filing to BSE today.
The tablets are generic versions of Merck Sharp & Dohme Corporation.
The product will be commercialised from the company’s Ghaziabad plant. Active Pharmaceutical Ingredient will also be made in-house at Pithampur/Roha API Plant, Unichem Laboratories said.
Shares of Unichem Laboratories were trading at Rs 278 in afternoon trade on the BSE, up 2.32 per cent from the previous close.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.